FibroBiologics, Inc.
Pharmaceutical company · Houston, Texas, United States · Nasdaq: FBLG
FibroBiologics, Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker FBLG. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2026.
FibroBiologics at a glance
What does FibroBiologics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3 million sold (2026).
Frequently asked questions about FibroBiologics
Where is FibroBiologics headquartered?
FibroBiologics, Inc. is headquartered in Houston, Texas, United States.
What does FibroBiologics do?
FibroBiologics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is FibroBiologics a public company?
Yes. FibroBiologics, Inc. trades on Nasdaq under the ticker FBLG.
When was FibroBiologics founded?
The earliest incorporation on record for FibroBiologics, Inc. is in 2021, according to public company registers.
Similar companies
- Marker Therapeutics, Inc.Houston, Texas, United States
- 7 Hills Pharma Inc.Houston, Texas, United States
- Decoy Therapeutics Inc.Houston, Texas, United States
- CNS Pharmaceuticals, Inc.Houston, Texas, United States
- Coya Therapeutics, Inc.Houston, Texas, United States
- Aravive, Inc.Houston, Texas, United States
- Beta Cat Pharmaceuticals, Inc.Houston, Texas, United States
- Moleculin Biotech, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences